Evidence map›Paper›PMID 38631429›Full record

ArticleAnnals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology2024

The association of infant urinary adrenal steroids with the risk of childhood asthma development.

Kedir N Turi, Yajing Li, Yaomin Xu, Tebeb Gebretsadik, Christian Rosas-Salazar, Derek A Wiggins, Chris McKennan, Dawn Newcomb, James E Gern, Tina V Hartert

Open access · greenAbstract read
In one paragraph

Article in Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 4 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Kedir N TuriDepartment of Epidemiology and Biostatistics, Indiana University, Bloomington, Indiana. Electronic address: knturi@iu.edu.
Yajing LiDepartment of Biostatistics, Vanderbilt University Medical Center, Nashville, Tennessee.
Yaomin XuDepartment of Biostatistics, Vanderbilt University Medical Center, Nashville, Tennessee.
Tebeb GebretsadikDepartment of Biostatistics, Vanderbilt University Medical Center, Nashville, Tennessee.
Christian Rosas-SalazarDepartment of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee.
Derek A WigginsDepartment of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.
Chris McKennanDepartment of Statistics, University of Pittsburgh, Pittsburgh, Pennsylvania.
Dawn NewcombDepartment of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.
James E GernDepartment of Pediatrics, University of Wisconsin, Madison, Wisconsin.
Tina V HartertDepartment of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee; Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee. Electronic address: tina.hartert@vumc.org.
Vanderbilt University Medical Center · USIndiana University Bloomington · USUniversity of Pittsburgh · USUniversity of Wisconsin–Madison · US

Funding

Vanderbilt Institute for Clinical and Translational Research (VICTR) -Identifying correlates of functional immunity in SARS-CoV-2 convalescent plasmaUL1TR002243 · NCATS · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Paul A. Harris, Wesley H Self · 2017 to 2026
$130.7M
Wisconsin Infant Study Cohort (WISC) ECHO Pediatric Follow-UpUH3OD023282 · OD · UNIVERSITY OF WISCONSIN-MADISON · PI James E. Gern · 2018 to 2026
$64.8M
Viral and Host Determinants of Infant and Childhood Allergy and AsthmaU19AI095227 · NIAID · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Tina V Hartert · 2011 to 2026
$34.9M
Wisconsin Infant Study Cohort (WISC) ECHO Pediatric Follow-UpUG3OD023282 · OD · UNIVERSITY OF WISCONSIN-MADISON · PI GERN, JAMES E. · 2016 to 2024
$19.3M
Pathogenesis, Targeted Therapeutics, and New Vaccines for Childhood DiseaseK12HD087023 · NICHD · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Michael R. DeBaun, Juan C Salazar · 2016 to 2026
$4.1M
The effect of early-life nasal colonization with Lactobacillus on the development of the local immune response and the later onset of recurrent wheeze, childhood asthma, and allergic rhinitisK23HL148638 · NHLBI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI ROSAS-SALAZAR, CHRISTIAN · 2019 to 2023
$909k
Multi-Omic Endotyping of AsthmaK01HL146980 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI KELLY, RACHEL SABINE · 2019 to 2023
$891k
Identification of Early Metabolomic and Immune Endotypes of Allergy and Asthma: An Integrated Multiomics ApproachK01HL149989 · NHLBI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI TURI, KEDIR NESHA · 2020 to 2024
$810k
NCATS NIH HHS UL1 TR002243NHLBI NIH HHS K01 HL146980NHLBI NIH HHS K01 HL149989NHLBI NIH HHS K23 HL148638NIAID NIH HHS U19 AI095227NICHD NIH HHS K12 HD087023NIH HHS UG3 OD023282NIH HHS UH3 OD023282
6 · The paper itself

Abstract

backgroundAdrenal steroids play important roles in early-life development. However, our understanding of the effects of perinatal adrenal steroids on the development of childhood asthma is incomplete.

objectiveTo evaluate the associations between early-life adrenal steroid levels and childhood asthma.

methodsParticipants included the Infant Susceptibility to Pulmonary Infections and Asthma following Respiratory Syncytial Virus Exposure birth cohort children with untargeted urinary metabolomics data measured during early infancy (n = 264) and nasal immune mediator data measured concurrently at age 2 to 6 months (n = 76). A total of 11 adrenal steroid compounds were identified using untargeted metabolomics and 6 asthma-relevant nasal immune mediators from multiplex assays were a priori selected. Current asthma at ages 5 and 6 years was ascertained using validated questionnaires. Associations were tested using logistic and linear regression with confounders adjustment.

resultsPregnenetriol disulfate (adjusted odds ratio [aOR] = 0.20, 95% CI = 0.06-0.68) and 3a,21-dihydroxy-5b-pregnane-11,20-dione-21-glucuronide (aOR = 0.34, 95% CI = 0.14-0.75) were inversely associated with childhood asthma at 5 and 6 years after multiple testing adjustment. There was a significant interaction effect of pregnanediol-3-glucuronide by biological sex assigned at birth (aOR = 0.11, 95% CI = 0.02-0.51, for those with female sex) on childhood asthma. Pregnenetriol disulfate was inversely associated with granulocyte-macrophage colony-stimulating factor (β = -0.45, q-value = 0.05). 3a,21-dihydroxy-5b-pregnane-11,20-dione 21-glucuronide was inversely associated with interleukin [IL]-4 (β = -0.29, q-value = 0.02), IL-5 (β = -0.35, q-value = 0.006), IL-13 (β = -0.26, q-value = 0.02), granulocyte-macrophage colony-stimulating factor (β = -0.35, q-value = 0.006), and fibroblast growth factor-β (β = -0.24, q-value = 0.01) after multiple testing adjustment.

conclusionThe inverse association between adrenal steroids downstream of progesterone and 17-hydroxypregnenolone and the odds of childhood asthma and nasopharyngeal type 2 immune biomarkers suggest that increased early-life adrenal steroids may suppress type 2 inflammation and protect against the development of childhood asthma.

Indexed as

AsthmaAdrenal Cortex HormonesChildChild, PreschoolFemaleHumansInfantMaleRespiratory Syncytial Virus InfectionsRisk FactorsAdrenal Cortex Hormones

Identifiers

PMID38631429
PMCPMC11298305
OpenAlexW4394824131

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.